State Street Corporation 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 07:52 am Sale |
2024-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
1,326,158 4.900% |
-303,508 (-18.62%) |
Filing |
| 2024-01-25 07:48 am Sale |
2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
1,629,666 6.100% |
-38,259 (-2.29%) |
Filing |
| 2023-10-10 11:20 am Sale |
2023-09-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
1,667,925 6.270% |
-589,921 (-26.13%) |
Filing |
| 2023-02-08 09:52 am Sale |
2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
2,257,846 8.500% |
-960,111 (-29.84%) |
Filing |
| 2022-04-11 1:47 pm Purchase |
2022-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
3,217,957 12.200% |
1,161,883 (+56.51%) |
Filing |
| 2022-02-11 09:40 am Purchase |
2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
STATE STREET CORP STT |
2,056,074 7.800% |
2,056,074 (New Position) |
Filing |